Related Experiment Video
Updated: Apr 25, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing,
Gaston K Rivera1, Raul C Ribeiro
1International Outreach Program and Department of Oncology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
Insights
Cure rates for pediatric acute lymphoblastic leukemia (ALL) vary globally. This study suggests using communication technology to foster partnerships and improve ALL treatment in developing nations, reducing mortality.
Area of Science:
- Pediatric Oncology
- Global Health Equity
Background:
- Cure rates for pediatric acute lymphoblastic leukemia (ALL) significantly differ between high- and low-income countries.
- Limited hospital infrastructure and resources in lower-income nations contribute to higher treatment-related mortality and suboptimal patient compliance.
- Current upfront risk assignment strategies for individualizing ALL therapy require technical resources and expertise often unavailable in resource-limited settings.
Purpose of the Study:
- To provide evidence-based suggestions for managing childhood ALL in developing countries.
- To explore the role of communication technology in improving pediatric oncology care.
- To enhance patient outcomes by optimizing resource allocation and treatment intensity.
Main Methods:
- Literature review and synthesis of current management strategies for childhood ALL.
- Analysis of challenges faced in resource-limited settings for pediatric cancer treatment.
- Proposal of collaborative models utilizing communication technology for knowledge and resource sharing.
Main Results:
- Disparities in ALL cure rates are linked to socioeconomic factors and healthcare infrastructure.
- Effective management requires adapting treatment protocols to local capabilities.
- Collaborative partnerships can facilitate access to expertise and resources, improving patient care.
Conclusions:
- Implementing communication technology is crucial for sustaining international pediatric oncology partnerships.
- Collaborations should focus on prioritizing resources, identifying local challenges, and tailoring treatment intensity.
- These strategies aim to reduce treatment-related morbidity and mortality, particularly for lower-risk pediatric ALL patients.
Abstract:
Cure rates for pediatric acute lymphoblastic leukemia differ markedly in higher- and lower-income countries due to disparate hospital infrastructure and resources. Where means are limited, treatment-related mortality is higher and compliance may be suboptimal. Upfront risk assignment is aimed at individualizing therapy according to presenting features in order to avoid over- or under-treatment. However, the necessary technical resources and expertise are not always readily available. The authors provide suggestions for management of childhood acute lymphoblastic leukemia in developing nations. To improve patient care locally, the authors recommend that communication technology be used to sustain partnerships between sponsoring and partner pediatric oncology programs. The aims of these collaborations should be to prioritize resources, identify existing problems and reduce treatment intensity and hence treatment-related morbidity and mortality in patients at lower risk of relapse.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

